Atlanta and Brussels (ots/PRNewswire) - - BRIVIACT® (brivaracetam) CV oral formulations are approved as a monotherapy or adjunctive therapy in patients four years of age and older with partial-onset seizures - Approval provides pediatric epilepsy patients a treatment option which can be initiated at a therapeutic ...
Cambridge, England (ots/PRNewswire) - SciBite (https://www.scibite.com/), the award-winning semantic analytics company, today announced a strategic partnership with ChemAxon (https://chemaxon.com/), the leading cheminformatics company, enabling Pharmaceutical companies to capitalise on unlocking the wealth of R&D data that is at their disposal. (Logo: ...
Darmstadt, Germany (ots/PRNewswire) - - Post-hoc analysis from the 2-year CLARITY study demonstrated that Mavenclad reduced the risk of 6-month EDSS progression by 47% vs placebo - Patients with highly active multiple sclerosis had an even greater treatment effect, reducing the risk by 82% vs placebo Merck, a ...
Stockholm (ots/PRNewswire) - BioLamina (http://www.biolamina.com) (Stockholm) is currently undergoing an exciting phase entering the growing cell and gene therapy reagents industry. In order to meet the growing demand for documentation and traceability required for the manufacture of cells for therapy, BioLamina has ...
Brussels (ots/PRNewswire) - Strictly not for UK/Irish media - CIMZIA® (certolizumab pegol) Phase 3 psoriasis data demonstrated significant and clinically meaningful improvements in biologic-naïve and previously treated patients, with clinical benefit maintained up to one year[1] - This milestone represents UCB's ...
Constance Therapeutics and Kanabo Research
Tel Aviv, Israel (ots/PRNewswire) - Israeli startup Kanabo Research (http://www.kanaboresearch.com/), which develops clinical solutions for extraction and vaporization of medical cannabis, announces it is entering an agreement with Constance Therapeutics, a US-based medical cannabis extraction company. (Photo: ...
South San Francisco, California, USA and Schlieren, Switzerland (ots) - AI genomics company Freenome announces partnership with leading proteomics company Biognosys to enhance its broad-signal approach to early-cancer detection and precision oncology. By decoding cell-free (cf) biomarker patterns of once unthinkable ...
Luxembourg (ots/PRNewswire) - Inceptua Group (previously Multipharma) today announces that its Clinical Trial Supplies business unit is rebranding to Inceptua Clinical Trial Services. Going forward, all of the group's three business units including Clinical Trial Services, Medicines Access and Commercial Products will be marketed under the same corporate brand name, ...
Brussels (ots/PRNewswire) - - Midazolam Nasal Spray (USL261), is a nasally administered investigational midazolam formulation intended as a rescue treatment of acute repetitive seizures (ARS) in patients with epilepsy, which has completed Phase 3 clinical development and is ready to be filed as a New Drug ...
Geneva (ots) - FDI World Dental Federation published two resources - a white paper and a practical guide - as part of its Global Periodontal Health Project (GPHP), which aims to bring attention to periodontal health as a priority area for policy worldwide. "Periodontal disease - or gum disease as it is often better known - is one of the most common diseases affecting ...
Amsterdam (ots/PRNewswire) - Norgine B.V. today announced that its UK affiliate has received funding for ENDOCUFF VISION® through the NHS Innovation Technology Payment 2018/19 (ITP) scheme. The NHS ITP Programme aims to support the NHS in adopting innovation by removing financial or procurement barriers to uptake of innovative products or technologies and is a ...
Brussels (ots/PRNewswire) - - Acquisition to strengthen UCB's genomics and epigenomics research platform to identify novel drug targets UCB announces the acquisition of Element Genomics, a small-size biotech spin-off from Duke University, based in Durham, North Carolina (USA). The total cost of the transaction, ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - Japanese Ministry of Health, Labour and Welfare Grants SAKIGAKE designation for tepotinib, Merck's investigational highly selective c-Met receptor tyrosine kinase inhibitor - First regulatory designation for tepotinib - SAKIGAKE ...
Leuven, Belgium and Osaka, Japan (ots/PRNewswire) - - First allogeneic stem cell therapy to receive central marketing authorization approval in Europe - Alofisel offers a new treatment option for patients who do not respond to current available therapies and may be subject to numerous invasive surgeries[1] TiGenix ...
Rehovot, Israel (ots/PRNewswire) - Kanabo Research, a Tel-Aviv-based medical cannabis R&D company, announced that it has signed a partnership agreement with Jupiter Research, an innovative manufacturer of high-performance inhalation hardware and technology for plant based extracts. (Photo: https://mma.prnewswire.com/media/657554/KANABO_Mark_and_Avihu.jpg ) The partnership agreement was officially signed during the ...
Staines-Upon-Thames, England (ots/PRNewswire) - EUR50,000 award goes to Rotherham NHS Foundation Trust Department of Haematology Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, today announced the inaugural recipient of its Advancing Extracorporeal Photopheresis (ECP) Immunomodulation Investigator Award. The winning entry was submitted by ...
Chicago (ots/PRNewswire) - Oral session #12 Adults with obesity treated with semaglutide 0.4 mg administered once-daily via subcutaneous injections lost up to 13.8% of their body weight after 52 weeks in a phase 2 trial, significantly more than those treated with placebo who lost 2.3% of their body weight.[1] An ...
Zurich, SWITZERLAND (ots) - Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis Sequana Medical AG ("Sequana Medical"), a commercial stage medical device company and an innovator in the management of ...
Stockholm (ots/PRNewswire) - OxThera AB, a Stockholm-based privately-held biopharmaceutical company with a product in late stage clinical development focusing on Primary hyperoxaluria (PH), announces the randomization of the first patient into its phase III study, EPHEX, with Oxabact. Study OC5-DB-02 (EPHEX) is a ...
Rehovot, Israel (ots/PRNewswire) - Israel becomes the first country in the world to grant medical device approval for a medical cannabis vaporizer Kanabo Research, a Tel-Aviv-based medical cannabis R&D company, is pleased to announce that the Israeli Ministry of Health has granted initial approval as a medical ...
Ganterschwil (ots) - The Board of Directors of Berlinger Special AG has resolved that the company will cease production of its doping control kits in the medium term. To avoid jeopardizing current anti-doping activities, the company will continue to supply its present customers at their request for a transitional ...
Amsterdam (ots/PRNewswire) - Debuted at ECR 2018, the newest addition to Philips' digital MR solutions portfolio provides breakthrough in speed, improved patient experience and clinical confidence Royal Philips (http://www.philips.com/) (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced ...
Hitachi Medical Systems Europe Holding AG
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.K./U.S. based media - First oral short-course treatment for highly active relapsing multiple sclerosis (RMS) now approved in Argentina - Mavenclad has shown sustained clinical efficacy for up to 4 years with a maximum of 20 days of oral treatment over 2 years Merck, a leading science and technology company, today ...
Amsterdam (ots/PRNewswire) - Arc Medical Design Limited, a subsidiary of Norgine B.V., today announced that the High Court of Justice England and Wales, Patents Court ruled that ENDOCUFF® and ENDOCUFF VISION® UK national and UK(EP) patents (as amended) are valid and infringed by Cantel's AmplifEYE® endoscopic ...
Haifa, Israel and Miami (ots/PRNewswire) - INSIGHTEC®, a commercial-stage medical technology company revolutionizing surgery with incisionless MR-guided focused ultrasound (MRgFUS) announced today that the Neuravive focused ultrasound treatment will be a covered service for essential tremor patients in Israel. The ...
Takeda Pharmaceutical Company Limited
Osaka, Japan (ots/PRNewswire) - New clinical study also provides data for Entyvio® in inducing complete mucosal healing and endoscopic remission, particularly in bio-naïve patients Takeda Pharmaceutical Company Limited (TSE: 4502) ("Takeda") today announced new real-world data evaluating the comparative ...
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for UK-based media Merck and Pfizer Inc. (NYSE: PFE) today announced results from the Phase III JAVELIN Lung 200 trial comparing avelumab* to docetaxel in patients with unresectable, recurrent or metastatic non-small cell lung cancer (NSCLC) whose ...
Lausanne (ots) - Debiopharm Group (TM) announces an investment in antibiotic development with the acquisition of a minority stake in ABAC Therapeutics Inc. This investment was made through the Debiopharm Innovation Fund, its strategic investment fund, and illustrates the synergy between the group companies in the ...